SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-045782
Filing Date
2023-08-31
Accepted
2023-08-31 16:05:57
Documents
2
Period of Report
2023-08-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1535
2 EX-24 tngx-ex24.htm EX-24 9642
  Complete submission text file 0000950170-23-045782.txt   12658
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TANGO THERAPEUTICS, INC. 201 BROOKLINE AVE., SUITE 901 BOSTON MA 02215
Business Address
Ketchum John B (Reporting) CIK: 0001991806 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39485 | Film No.: 231229042